This article is for informational and educational purposes only. It does not constitute medical advice. BPC-157 is an investigational compound that has not been approved by the FDA. Patients with cardiovascular conditions or those taking cardiac medications should consult their cardiologist before using any peptide supplement. UTCardiothoracicSurgery.com Editorial Team | July 2026. This article may contain affiliate links. Commissions may be earned at no additional cost to you through qualifying purchases. FTC disclosure required by 16 C.F.R. Part 255.
Quick Answer: ProHealth Longevity BPC-157 is a synthetic peptide supplement (500 mcg per capsule, arginate salt form) with preclinical research suggesting tissue repair and gastroprotective properties. Notably, BPC-157 has cardiovascular research implications — animal studies have examined its effects on blood pressure regulation, nitric oxide pathways, and vascular healing. For cardiac patients, this means the peptide may interact with blood pressure medications and NO-dependent vasodilators through pathways that are not yet characterized in human studies. This is an investigational compound requiring serious physician consultation.
In This Article
Why BPC-157 Warrants Cardiac-Specific Analysis
Unlike most supplements reviewed by the UTCTS Health Review Desk, BPC-157 has direct cardiovascular research relevance rather than incidental cardiac interaction risk. Published preclinical studies have specifically examined BPC-157's effects on blood vessel formation, blood pressure modulation, and nitric oxide signaling — the same pathways targeted by common cardiac medications including nitrates, ACE inhibitors, and calcium channel blockers. General supplement reviews typically mention BPC-157's gut health and tissue repair potential while omitting its vascular research profile. This review corrects that omission.
Verified Product Details
ProHealth Longevity BPC-157 delivers 500 mcg of BPC-157 Arginate Salt per capsule, 60 capsules per bottle (one-month supply at two capsules daily). ProHealth specifically selected the arginate salt form over the more common acetate form, citing improved gastrointestinal stability. The company has maintained over 35 years of industry presence and holds a Better Business Bureau A+ rating. The product undergoes triple independent third-party laboratory testing for quality assurance. It includes a 100-day money-back guarantee.
The Evidence Base: What Exists and What Does Not
BPC-157 is a synthetic 15-amino acid peptide originally derived from human gastric juice proteins. Its research profile is extensive in preclinical models but nearly absent in human clinical trials. The distinction matters significantly:
What preclinical research shows: Animal model studies have demonstrated BPC-157's effects on connective tissue healing, gastrointestinal mucosal protection, inflammatory modulation, and — critically for cardiac patients — vascular function. Studies in rats have examined BPC-157's interaction with nitric oxide (NO) pathways, its effects on blood pressure in hypertensive models, and its potential to influence angiogenesis (new blood vessel formation).
What human research shows: Essentially nothing of clinical significance. No published randomized controlled trials in humans exist for BPC-157 at the time of this review. All efficacy claims derive from animal models, typically rodent studies. The translation of these findings to human cardiovascular physiology is entirely speculative at this point.
Dose translation problem: Animal study doses are frequently administered via injection rather than oral consumption, at doses that may not correspond to the 500 mcg oral capsule format. The bioavailability of oral BPC-157 arginate salt in humans has not been established in published peer-reviewed literature.
Cardiac Safety Profile
The cardiovascular research implications of BPC-157 create a unique safety profile that requires detailed analysis:
Nitric oxide pathway interaction: Preclinical studies suggest BPC-157 may modulate nitric oxide signaling. Patients taking nitrates (nitroglycerin, isosorbide mononitrate) for angina, or PDE5 inhibitors, should be aware of theoretical additive vasodilatory effects. Excessive vasodilation can cause dangerous hypotension. While human evidence does not exist, the preclinical signal warrants caution.
Blood pressure effects: Animal studies have examined BPC-157 in hypertensive models, with some showing blood pressure-modulating effects. Patients on ACE inhibitors (lisinopril, enalapril), ARBs (losartan, valsartan), or calcium channel blockers (amlodipine, diltiazem) should discuss BPC-157 use with their cardiologist, as additive hypotensive effects are theoretically possible.
Angiogenesis concerns: Some preclinical research suggests BPC-157 may promote new blood vessel formation. While this could theoretically benefit tissue repair, unregulated angiogenesis raises concerns in patients with certain cardiovascular conditions, including those with a history of proliferative vascular disease or certain types of heart failure where vascular remodeling is a factor.
Anticoagulation status: No published data addresses BPC-157's interaction with warfarin, DOACs, or antiplatelet agents. The absence of data is not reassurance — it is a knowledge gap that should inform cautious decision-making.
Post-surgical patients: The tissue-healing properties that make BPC-157 appealing to some patients could theoretically affect wound healing dynamics post-cardiac surgery. Patients within 90 days of any cardiac procedure should avoid investigational compounds without explicit physician approval.
Label vs. Marketing Assessment
ProHealth's marketing is more restrained than many supplement brands, reflecting the company's established reputation and BBB A+ rating. The product page references “emerging research” rather than making definitive health claims. However, the consumer peptide market broadly overstates BPC-157's proven benefits. Much of the enthusiasm surrounding BPC-157 derives from social media testimonials and fitness community anecdotes rather than clinical evidence. ProHealth's specific product does not appear to make egregious claims, but the broader market context may create inflated consumer expectations.
User-Reported Outcomes
User experiences reflect the investigational nature of this compound. Some users report subjective improvements in digestive comfort and recovery from physical training. One documented user case described combining BPC-157 with collagen and vitamin C during eight weeks of Achilles tendon rehabilitation, reporting subjective recovery acceleration. However, user experiences are anecdotal, highly variable, and cannot be attributed specifically to BPC-157 versus concurrent interventions, natural healing, or placebo effect. The most satisfied users approach BPC-157 with realistic expectations about its investigational status.
Pricing and Refund Terms
ProHealth BPC-157 is priced at $119.95 per 60-capsule bottle (one-month supply). This reflects premium positioning within the peptide supplement category. Available through the ProHealth website and authorized retailers including iHerb. The 100-day money-back guarantee allows extended evaluation. Pricing is subject to change. Verify current pricing on the manufacturer's official listing.
Buyer Takeaway
ProHealth BPC-157 is a well-manufactured product from a reputable company, but it delivers an investigational compound with direct cardiovascular research relevance and zero human clinical trial data. For cardiac patients, the nitric oxide pathway interactions, blood pressure effects, and angiogenesis potential create a risk profile that demands cardiologist consultation before use — not as a formality, but as a genuine safety requirement. The compound may eventually prove beneficial, but the current evidence base cannot distinguish therapeutic benefit from theoretical risk in human cardiovascular patients. Readers on nitrates, ACE inhibitors, ARBs, calcium channel blockers, or anticoagulants should treat this product as contraindicated until cleared by their prescribing physician.
Related Reading
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. BPC-157 is an investigational compound. This article is for educational purposes only and does not constitute medical advice. Results vary by individual. Consult your physician before starting any supplement, particularly if you take cardiovascular or metabolic medications.